You are here: Industry Insights > Influenza

News List

Influenza A vaccine enters Phase IIb trial europeanpharmaceuticalreview
June 10, 2019
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
Single vaccination approach developed to combat respiratory diseases europeanpharmaceuticalreview
May 24, 2019
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
Daiichi Sankyo fails to hold up influenza vaccine project biospectrumasia
May 20, 2019
Daiichi Sankyo Announces Update to H5N1 Influenza Vaccine National Project
Flu’s response to Xofluza explored europeanpharmaceuticalreview
April 22, 2019
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge…
Further advances in cell-based influenza vaccine technology announced firstwordpharma
April 18, 2019
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
WHO launches its most far-reaching strategy against influenza globally pharmaceutical-technology
March 13, 2019
The WHO views annual vaccination as the best method to prevent influenza. Credit: NIAID via Flickr.
FDA accepts Genentech's XOFLUZA for the treatment of Influenza biospectrumasia
March 07, 2019
The sNDA is based on results from the Phase III CAPSTONE-2 study of a single dose of XOFLUZA compared with placebo or oseltamivir 75 mg, twice daily for five days, in people 12 years of age or older who are at high risk of complications from the flu.
Why China's flu vaccine supply is suffering this season fiercepharma
December 11, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down...
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza pharmafocusasia
November 27, 2018
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease...
Vaxart touts head-to-head data for oral flu vaccine versus Sanofi's Fluzone fiercepharma
November 09, 2018
Aiming to challenge flu shot market leader Sanofi, Vaxart put up phase 2 data for an oral flu vaccine candidate that the biotech says provided participants both mucosal

Previous page 1 2 3 4 5 6 Next page